MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
213.48%
Quick Ratio
195.61%
Cash Ratio
171.10%
Debt to Asset Ratio
122.71%
Unit: Thousand (K) dollars
Assets Breakdown
    • Intangible asset, net
    • Cash and cash equivalents
    • Accounts receivable
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid in capital
    • Pfizer promissory note
    • Others
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
11,002
13,026
Accounts receivable
448
-
Inventory
1,149
948
Income taxes receivable
0
0
Prepaid expenses and other current assets
1,128
916
Total current assets
13,727
14,890
Intangible asset, net
18,710
19,059
Property and equipment, net
18
12
Restricted cash
29
34
Other assets
19
19
Total assets
32,503
34,014
Accounts payable
577
1,189
Accrued expenses
5,216
3,951
Exchangeable notes
0
0
Royalty-linked notes
281
190
Income taxes payable
24
6
Other current liabilities
332
197
Total current liabilities
6,430
5,533
Pfizer promissory note
21,215
20,653
Royalty-linked notes
12,239
11,715
Total liabilities
39,884
37,901
Ordinary shares, 0.01 par value per share 80,000,000 shares authorized at september 30, 2025 and december 31, 2024, 48,991,860 shares issued at september 30, 2025 31,534,233 shares issued at december 31, 2024
490
421
Additional paid in capital
498,580
493,164
Accumulated other comprehensive income
-
0
Accumulated deficit
-506,451
-497,472
Total shareholders' deficit
-7,381
-3,887
Total liabilities and shareholders' deficit
32,503
34,014
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$11,002K Inventory$1,149K Prepaid expenses andother current assets$1,128K Accounts receivable$448K Intangible asset, net$18,710K Total current assets$13,727K Restricted cash$29K Other assets$19K Property and equipment,net$18K Total assets$32,503K Accumulated deficit-$506,451K Total liabilities andshareholders' deficit$32,503K Total shareholders'deficit-$7,381K Additional paid in capital$498,580K Ordinary shares, 0.01 parvalue per share...$490K Total liabilities$39,884K Pfizer promissory note$21,215K Royalty-linked notes$12,239K Total currentliabilities$6,430K Accrued expenses$5,216K Accounts payable$577K Other currentliabilities$332K Royalty-linked notes$281K Income taxes payable$24K

Iterum Therapeutics plc (ITRM)

Iterum Therapeutics plc (ITRM)